• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.08%

    Ligand Pharmaceuticals Incorporated (LGND)

    -NasdaqGM
    98.60 Up 1.51(1.56%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Prev Close:97.09
    Open:96.83
    Bid:98.48 x 100
    Ask:98.94 x 100
    1y Target Est:106.40
    Beta:0.56
    Earnings Date:Aug 3 - Aug 7 (Est.)
    Day's Range:96.13 - 98.66
    52wk Range:41.99 - 102.24
    Volume:243,225
    Avg Vol (3m):433,686
    Market Cap:1.94B
    P/E (ttm):196.02
    EPS (ttm):0.50
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for LGND

    Comparison

    Symbol% ChgMkt Cap
    LGNDUp 1.56%1.94B
    LLYUp 1.52%91.22B
    MRKUp 0.12%162.93B
    RHHBYUp 0.09%N/A

    Key Statistics

    Forward P/E (1 yr):29.70
    P/S (ttm):30.22
    Ex-Dividend Date:02-Jul-10

    Analysts

    Annual EPS Est (Dec-15) :2.84
    Quarterly EPS Est (Jun-15) :1.06
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):0.74

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Ligand Pharmaceuticals Incorporated operates as a biotechnology company in the United States. The company’s commercial programs include Promacta, an oral medicine that increases the number of platelets in the blood; Kyprolis that is used for ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback